Huang Qin Tang Can Reduce The Gastrointestinal Toxicity Damage from Cancer Chemotherapy

The paradigm of health needs in the world has changed from disease care to health care. Thus the scope of the medicine is not just for diseases treatment but also disease prevention. The existing western treatment for cancers still has its limitations to improve the therapeutic result of cancers. Multiple-target and polychemical medicine will be the trend for the future of medicine.

”Chinese Medicine could meet current significant unmet medical needs for novel treatment strategies. It could serve as the basis for developing future medicine,” says Dr. Yung-Chi Cheng, who is the Henry Bronson Professor of Pharmacology at the Yale University School of Medicine specializing in cancer and viral chemotherapy.

Dr.Cheng was invited to deliver the speech on “Why and how to globalize traditional Chinese medicine” for Traditional Chinese medicine community on cancer treatment at Chinese Medical association in Taipei in June, 2012.

Dr. Cheng talked about his laboratory experiment in developing PHY906, a Chinese medicine formula, Huang Qin Tang first described 1800 years ago, with claims for the treatment of chemotherapy patients’ severe diarrhea, nausea and vomiting. He believes PHY906 works in at least three different ways in the body to control the side effects of chemotherapy, whereas conventional medicine works in just a single way.

Evidence for clinical efficacy and the safety of TCM are the requirements of being accepted globally.